{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:36:03Z","timestamp":1761744963628},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","gastrojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1053\/j.gastro.2019.04.031","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T15:12:18Z","timestamp":1556291538000},"page":"2128-2130.e4","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Present State and Future Direction of Regenerative Medicine for Perianal Crohn\u2019s Disease"],"prefix":"10.1053","volume":"156","author":[{"given":"Amy L.","family":"Lightner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2019.04.031_bib1","first-page":"33","article-title":"Management of complex perianal Crohn's disease","volume":"30","author":"Aguilera-Castro","year":"2017","journal-title":"Ann Gastroenterol"},{"key":"10.1053\/j.gastro.2019.04.031_bib2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/DCR.0b013e3181ce8b01","article-title":"Endorectal advancement flap for cryptoglandular or Crohn's fistula-in-ano","volume":"53","author":"Soltani","year":"2010","journal-title":"Dis Colon Rectum"},{"key":"10.1053\/j.gastro.2019.04.031_bib3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00384-003-0490-3","article-title":"Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapy","volume":"18","author":"Garcia-Olmo","year":"2003","journal-title":"Int J Colorectal Dis"},{"key":"10.1053\/j.gastro.2019.04.031_bib4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3727\/096368912X656045","article-title":"Autologous adipose tissue-derived stem cells for the treatment of Crohn's fistula: a phase I clinical study","volume":"22","author":"Cho","year":"2013","journal-title":"Cell Transplant"},{"key":"10.1053\/j.gastro.2019.04.031_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.gastro.2017.04.001","article-title":"Autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn's disease","volume":"153","author":"Dietz","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.04.031_bib6","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s10350-005-0052-6","article-title":"A\u00a0phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation","volume":"48","author":"Garcia-Olmo","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"10.1053\/j.gastro.2019.04.031_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/DCR.0b013e3181973487","article-title":"Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial","volume":"52","author":"Garcia-Olmo","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"10.1053\/j.gastro.2019.04.031_bib8","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1053\/j.gastro.2015.06.014","article-title":"Allogeneic bone marrow-derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn's disease","volume":"149","author":"Molendijk","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.04.031_bib9","doi-asserted-by":"crossref","first-page":"532","DOI":"10.5966\/sctm.2014-0199","article-title":"Long-term results of adipose-derived stem cell therapy for the treatment of Crohn's fistula","volume":"4","author":"Cho","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1053\/j.gastro.2019.04.031_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00384-012-1581-9","article-title":"Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I\/IIa clinical trial","volume":"28","author":"de la Portilla","year":"2013","journal-title":"Int J Colorectal Dis"},{"key":"10.1053\/j.gastro.2019.04.031_bib11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","article-title":"Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial","volume":"388","author":"Panes","year":"2016","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2019.04.031_bib12","doi-asserted-by":"crossref","first-page":"F31","DOI":"10.1152\/ajprenal.00007.2005","article-title":"Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms","volume":"289","author":"Togel","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.gastro.2019.04.031_bib13","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1053\/j.gastro.2019.01.032","article-title":"Long-term safety and efficacy of local microinjection combining autologous microfat and adipose-derived stromal vascular fraction for the treatment of refractory perianal fistula in Crohn\u2019s disease","volume":"156","author":"Serraro","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.04.031_bib14","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1053\/j.gastro.2019.02.005","article-title":"Efficacy of injection of freshly collected autologous adipose tissue into perianal fistulas in patients with Crohn's disease","volume":"156","author":"Dige","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.04.031_bib15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nbt.2816","article-title":"Mesenchymal stem cells: immune evasive, not immune privileged","volume":"32","author":"Ankrum","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1053\/j.gastro.2019.04.031_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","article-title":"Stem cell therapies in clinical trials: progress and challenges","volume":"17","author":"Trounson","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1053\/j.gastro.2019.04.031_bib17","article-title":"Allogeneic mesenchymal stromal cells transplanted onto the heart surface achieve therapeutic myocardial repair despite immunologic responses in rats","volume":"5","author":"Tano","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1053\/j.gastro.2019.04.031_bib18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.2010.214841","article-title":"Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease","volume":"60","author":"Ciccocioppo","year":"2011","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2019.04.031_bib19","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1002\/stem.1357","article-title":"Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula","volume":"31","author":"Lee","year":"2013","journal-title":"Stem Cells"},{"key":"10.1053\/j.gastro.2019.04.031_bib20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2249.2007.03422.x","article-title":"Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells","volume":"149","author":"Ryan","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.gastro.2019.04.031_bib21","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","article-title":"Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation","volume":"103","author":"Meisel","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.gastro.2019.04.031_bib22","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/stem.1483","article-title":"Mesenchymal stem cells inhibit cutaneous radiation-induced fibrosis by suppressing chronic inflammation","volume":"31","author":"Horton","year":"2013","journal-title":"Stem Cells"},{"key":"10.1053\/j.gastro.2019.04.031_bib23","doi-asserted-by":"crossref","first-page":"583409","DOI":"10.1155\/2014\/583409","article-title":"Immunoregulatory effects of bone marrow-derived mesenchymal stem cells in the nasal polyp microenvironment","volume":"2014","author":"Pezato","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1053\/j.gastro.2019.04.031_bib24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00054725-200303000-00003","article-title":"Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement","volume":"9","author":"Regueiro","year":"2003","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2019.04.031_bib25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10350-004-6611-4","article-title":"Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience","volume":"46","author":"Topstad","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"10.1053\/j.gastro.2019.04.031_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/1457496916665763","article-title":"Surgical management of fistula-in-ano among patients with Crohn's disease: analysis of outcomes after fistulotomy or Seton placement-single-center experience","volume":"106","author":"Papaconstantinou","year":"2017","journal-title":"Scand J Surg"},{"key":"10.1053\/j.gastro.2019.04.031_bib27","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1053\/j.gastro.2010.02.013","article-title":"Fibrin glue is effective healing perianal fistulas in patients with Crohn's disease","volume":"138","author":"Grimaud","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.04.031_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/ecco-jcc\/jjv162","article-title":"Fistula plug in fistulising ano-perineal Crohn's disease: a randomised controlled trial","volume":"10","author":"Senejoux","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2019.04.031_bib29","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/codi.13668","article-title":"Increasing experience of ligation of the intersphincteric fistula tract for patients with Crohn's disease: what have we learned?","volume":"19","author":"Kaminski","year":"2017","journal-title":"Colorectal Dis"},{"key":"10.1053\/j.gastro.2019.04.031_bib30","first-page":"147","article-title":"Endorectal advancement flap in perianal Crohn's disease","volume":"64","author":"Joo","year":"1998","journal-title":"Am Surg"},{"key":"10.1053\/j.gastro.2019.04.031_bib31","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s10620-017-4618-7","article-title":"The use of temporary fecal diversion in colonic and perianal Crohn's disease does not improve outcomes","volume":"62","author":"Bafford","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2019.04.031_bib32","doi-asserted-by":"crossref","first-page":"532","DOI":"10.5966\/sctm.2014-0199","article-title":"Long-term results of adipose-derived stem cell therapy for the treatment of Crohn's fistula","volume":"4","author":"Cho","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1053\/j.gastro.2019.04.031_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13287-015-0122-1","article-title":"Ex\u00a0vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact","volume":"6","author":"Ciccocioppo","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"10.1053\/j.gastro.2019.04.031_bib34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.gastro.2017.04.001","article-title":"Autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn's disease","volume":"153","author":"Dietz","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.04.031_bib35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/DCR.0b013e3181973487","article-title":"Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial","volume":"52","author":"Garcia-Olmo","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"10.1053\/j.gastro.2019.04.031_bib36","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1053\/j.gastro.2015.06.014","article-title":"Allogeneic bone marrow-derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn's disease","volume":"149","author":"Molendijk","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.04.031_bib37","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2017.12.020","article-title":"Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn's disease","volume":"154","author":"Panes","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.04.031_bib38","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","article-title":"Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial","volume":"388","author":"Panes","year":"2016","journal-title":"Lancet"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508519367241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508519367241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T21:18:35Z","timestamp":1573507115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508519367241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0016508519367241"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2019.04.031","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Present State and Future Direction of Regenerative Medicine for Perianal Crohn\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2019.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2019.02.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the AGA Institute","name":"copyright","label":"Copyright"}]}}